Department of Radiology, Stanford Medicine, Stanford, California.
Department of Interventional Radiology, Massachusetts General Hospital, 55 Fruit Street, GRB 298, Boston, Massachusetts.
J Vasc Interv Radiol. 2021 Apr;32(4):544-547. doi: 10.1016/j.jvir.2020.12.021.
This report evaluates the techniques and complications of microwave ablation of cystic renal cell carcinoma. Five patients with cystic renal cell carcinoma were treated with microwave ablation between October 2015 and June 2020. Medical records were reviewed to evaluate technique and complications. Technical success and primary technique efficacy both were 100%. There were no complications. Mean follow-up time was 18 months (range, 6-36 months). No local recurrence was identified during the follow-up period. Renal function remained stable at 1 month and the last follow-up. Percutaneous microwave ablation is promising for the nonsurgical management of cystic renal cell carcinoma.
本报告评估了微波消融囊性肾细胞癌的技术和并发症。2015 年 10 月至 2020 年 6 月，对 5 例囊性肾细胞癌患者进行了微波消融治疗。回顾病历以评估技术和并发症。技术成功率和主要技术疗效均为 100%。无并发症发生。平均随访时间为 18 个月（范围 6-36 个月）。随访期间未发现局部复发。肾功能在 1 个月和最后一次随访时保持稳定。经皮微波消融术有望成为囊性肾细胞癌的非手术治疗方法。
